Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: IMMUNANT, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Advanced Research Projects Agency
Period of performance: 2021-07-15 to 2024-10-30
Current total value of award: $1498543.96
Description: UNILATERAL MODIFICATION TO EXERCISE THE OPTION FOR CLIN 0003 AND 0004, EXTEND THE PERIOD OF PERFORMANCE, AND UPDATE THE COR.